-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enobosarm in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enobosarm in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Enobosarm in Obesity Drug Details: Enobosarm (Ostarine, GTx-024, MK-2866) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onabotulinumtoxin A in Myofascial Pain Syndrome (Chronic Myofascial Pain)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Myofascial Pain Syndrome (Chronic Myofascial Pain) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Myofascial Pain Syndrome...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onabotulinumtoxin A in Chronic Obstructive Pulmonary Disease (COPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Chronic Obstructive Pulmonary Disease (COPD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Chronic Obstructive Pulmonary Disease...
-
Product Insights
NewQuarterly Dried & Instant Noodles pricing trends in China
Empower your strategies with our Quarterly Dried & Instant Noodles pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
NewQuarterly Condiment Sauces pricing trends in China
Empower your strategies with our Quarterly Condiment Sauces pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
Hubei Huaneng Sui Xian Jieshan Wind Farm
Hubei Huaneng Sui Xian Jieshan Wind Farm is an Onshore Wind project located in Hubei, China. The project is owned and developed by Huaneng Power International Inc. The project came online in 2015. Empower your strategies with our Hubei Huaneng Sui Xian Jieshan Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
NewIncontinence Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Incontinence Devices Pipeline Market Report Overview Incontinence devices are externally, or internally worn devices intended to protect the skin from the involuntary loss of urine. The Incontinence Devices pipeline market research report provides extensive coverage of the Incontinence Devices under development. It reviews details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates. Additionally, it reviews major players involved in the pipeline product development....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enobosarm in Metastatic Breast Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Enobosarm in Metastatic Breast Cancer Drug Details: Enobosarm (Ostarine, GTx-024, MK-2866) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enobosarm in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Enobosarm in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onabotulinumtoxin A in Essential Tremor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Essential Tremor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Essential Tremor Drug Details: Onabotulinumtoxin A (Botox /...